PGK1 and breast cancer: Breast cancer patients with decreased miR-16-1-3p expression had shorter disease-free survival (Supplementary Figure 4A), and breast cancer patients with decreased PGK1 expression had longer disease-free survival (Supplementary Figure 4B).